Active Ingredient(s): Ocrelizumab
FDA Approved: * March 28, 2017
Pharm Company: * GENENTECH INC
Category: Immunosuppressive

Ocrelizumab, sold under the brand name Ocrevus, is a pharmaceutical drug for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal antibody.[3] It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug.[4] Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds.[4] It was approved by the U.S. Food and Drug Administration (FDA) in March 2017,[5] and th... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Ocrevus 300 mg/10ml Intravenous Injection
NDC: 50242-150
Genentech, Inc.

Popular Topics

Ocrevus - Burning skin sensation

Has anyone experienced a burning skin sensation from Ocrevus? For me, it is occurring in my back and buttocks. It is wor...

Ocrevus infusion time to take effect

How long do I have to wait for the medicine take effect? I still have a migraine and dizziness every day. I first infusi...

Ocrevus AWP pricing

I am trying to locate the AWP for Ocrevus. Any ideas? I have not been able to locate it anywhere. Thank you. ## Hi Nan, ...